Dry Weight Reduction Intervention Via Extra Ultrafiltration
NCT07637110
Blood Pressure Management, Cardiovascular Diseases
Seattle, Washington, United States
View Trial DetailsNCT Number: NCT06258616
The goal of this international inception cohort study is to describe fluid administration during admittance to the intensive care unit (ICU), and provide contemporary epidemiological data on fluid accumulation, risk factors, management and outcome in critically ill adult patients.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Deparment of Intensive care, Nordsjællands hospital, Hillerød, Denmark
Background: Fluid accumulation is associated with adverse outcome in ICU patients, however, assessment of fluid status is often difficult and no established definition and consistent detection method exists. Former research has primarily focused on the use of resuscitation fluid, but a substantial amount of fluid is administered throughout the entire ICU stay and this fluid may be a clinically relevant source of fluid accumulation.
Objectives: To describe fluid administration practices during the entire ICU stay, and provide contemporary epidemiological data on fluid accumulation, fluid removal, risk factors and association with patient outcomes from a worldwide perspective.
Study design: International inception cohort study. Patients will be included during a 14-day inception period to be chosen by each participating site.
Population: Critically ill adult patients (≥ 18 years) with acute admission to the ICU.
Intervention: None. Only routinely available data will be collected.
Study duration: Patients are followed daily until ICU discharge or death for a maximum of 28 days. Follow-up is performed 90 days after ICU admission.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From ICU admission to discharge (with a maximum of 28 days).
The presence of fluid accumulation is defined as the best clinical estimate made by the study investigators, using medical records and the treating team's clinical assessment, and one or more of the following parameters: Cumulative fluid balance, daily fluid balance, changes in body weight, and/or clinical signs of fluid accumulation (e.g. peripheral oedema, pulmonary oedema, congestion on chest X-ray or lung ultrasound).
Time frame: On the first day of ICU admission (Day 1).
Defined as the number of patients with fluid accumulation upon ICU admission or equal to the time of ICU assessed by study investigators using cumulative fluid balance, daily fluid balance, changes in body weight and clinical signs of fluid accumulation.
Time frame: 28 days
Defined as the number of patients developing fluid accumulation during ICU stay (one or more episodes) but no pre-existing fluid accumulation upon ICU admission (baseline form).
Time frame: 28 days
Defined as the median number of days with fluid accumulation in patient with fluid accumulation at baseline and/or during ICU stay at day 28 after ICU admission.
Time frame: 28 days
Defined as patients that receive treatment with any type of diuretics or renal replacement therapy.
Time frame: 28 days
Days alive without use of life-support (continuous infusion of vasopressors/inotropes, invasive mechanical ventilation or renal replacement therapy).
Time frame: 90 days
Total number of days alive and out of hospital within 90 days from ICU admission,
Time frame: 90 days
Death from all causes.
Time frame: Day 1-7 and after 28 days.
Definition: the median volume of all fluid in millilitres (mL) administered during ICU admission categorized by indication (resuscitation, maintenance-replacement, fluid creep, nutrition, blood products) reported on day 1, 2, 3, 4, 5, 6, 7 and 28 days after ICU admission.
Time frame: Day 1-7 and after 28 days
Definition: The sum of all daily fluid inputs minus all daily fluid outputs reported on day 1, 2, 3, 4, 5, 6, 7 and 28 days after ICU admission in mL (median).
Time frame: Day 1-7 and after 28 days.
Definition: Cumulative fluid balance will be calculated as the sum of all fluid input minus all fluid output reported on day 1, 2, 3, 4, 5, 6, 7 and 28 days after ICU admission in mL (median).
Contact information is provided by the study sponsor or research team.
Clara Molin, MD, PhD student
CONTACT
Morten Bestle, Professor, MD, PhD
CONTACT
Nordsjaellands Hospital
Other
Fluid Administration and Fluid Accumulation in the Intensive Care Unit (FLUID-ICU) - an International Inception Cohort Study
Acronym: FLUID-ICU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07637110
Blood Pressure Management, Cardiovascular Diseases
Seattle, Washington, United States
View Trial DetailsNCT07189091
Acute Kidney Injury, Critical Care, Intensive Care
Antwerp, Belgium
View Trial DetailsNCT07474116
Behavior, Body Weight
View Trial DetailsNCT03972475
Critical Care, Edema
Huddinge, Stockholm County, Sweden
View Trial Details